NCT02232503View on ClinicalTrials.gov

Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia

CompletedOBSERVATIONAL
Enrollment

4,011

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Diabetic RetinopathyDiabetic Macular EdemaDiabetes Mellitus
Interventions
GENETIC

Studied cohort

For the purpose of DNA isolation prior to genetic analysis of patients two samples of peripheral blood will be taken; first in the volume of 3.5 ml and second in the volume of 9 ml from each patient included into the study.

All Listed Sponsors
collaborator

Medirex Group Academy

UNKNOWN

collaborator

Slovak Technical University

UNKNOWN

collaborator

Comenius University

OTHER

lead

Novartis Slovakia, s.r.o.

INDUSTRY

NCT02232503 - Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia | Biotech Hunter | Biotech Hunter